When was Current Surgical founded?

Current Surgical was founded in 2019 and raised its 1st funding round 2 years after it was founded.

Where is Current Surgical located?

Current Surgical is headquartered in Washington, DC, United States.

How many employees does Current Surgical have?

As of Aug 31, 2026, the latest employee count at Current Surgical is 10.

Is Current Surgical a funded company?

Current Surgical is a funded company, having raised a total of $4M across 4 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on May 15, 2021.

When was the latest funding round of Current Surgical?

Current Surgical's latest funding was a $***** Grant (prize money) round on Aug 01, 2025, with participation from 1 investor.

Where does Current Surgical rank among its competitors?

Current Surgical ranks 12th amongst 26 active competitors, of which 8 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Cognos Therapeutics, which secured $250K in May, 2026.

Who are the top competitors of Current Surgical?

Current Surgical's top competitors include TriSalus Life Sciences, Delcath and Luminate Medical. Among them, Cognos Therapeutics secured the most recent funding round in May, 2026.

Current Surgical - 2026 Company Profile, Team, Funding & Competitors

Current Surgical is a seed company based in Washington, DC (United States), founded in 2019 by Al Mashal. It operates as a Developer of micro-invasive therapies for the treatment of solid tumors. Current Surgical has raised $4M in funding from True Ventures. The company has 26 active competitors, including 8 funded and 5 that have exited. Its top competitors include companies like TriSalus Life Sciences, Delcath and Luminate Medical.

Key Metrics

Founded Year

2019

Location

Washington, DC, United States

Stage

Seed

Total Funding

$4M in 4 rounds

Latest Funding Round

Grant (prize money), Aug 01, 2025, $*****

Investors

True Ventures & 4 more

Ranked

12^th among 26 active competitors

Employee Count

10 as on Aug 31, 2026

Similar Companies

TriSalus Life Sciences & 32 more

View Current Surgical's full profile

Current Surgical has raised a total funding of $4M over 4 rounds. Its first funding round was on May 15, 2021. Its latest funding round was a Grant (prize money) round on Aug 01, 2025 for $*****. 1 investor participated in its latest round. Current Surgical has 5 institutional investors.

Here is the list of recent funding rounds of Current Surgical:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 01, 2025	9251599	Grant (prize money)	7841104	8088188	4990810	3091700
Apr 01, 2023	8170697	Grant (prize money)	6917253	7092935	2142805	National Science Foundation
Feb 21, 2023	7139952	Seed	6793947	6564695	True Ventures	1517 Fund & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Current Surgical's funding rounds and investors

The founders of Current Surgical is Al Mashal.

Here are the details of Current Surgical's key team members:

Al Mashal: Co-founder and CTO of Current Surgical.
Contact Info: 1 email address

View details of Current Surgical's Founder profiles and Board Members

Current Surgical's employee count trend

Current Surgical has 10 employees as of Aug 26. Here is Current Surgical's employee count trend over the years:

Employee count trend for Current Surgical

Uncover Current Surgical's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Current Surgical include TriSalus Life Sciences, Delcath and Luminate Medical. Here is the list of Top 10 competitors of Current Surgical, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	TriSalus Life Sciences 2009, Westminster (United States), Public	Developer of drug delivery devices to treat cancers	$83.4M	Partisan Management Group, High Country Ventures ... & 7 others	66/100
2nd	Delcath 1987, New York City (United States), Public	Speciality Pharmaceutical and medical device company focused on oncology	-	BVF Partners, Vivo Capital & 8 others	61/100
3rd	Luminate Medical 2019, Galway (Ireland), Series A	Developer of a medical device to prevent hair loss during chemotherapy	$50M	Artis Ventures, Y Combinator & 12 others	57/100
4th	Embolx 2013, Sunnyvale (United States), Seed	Innovating arterial embolization with advanced microcatheter technology for targeted therapies	$500K	Sood Ventures, VI Ventures & 4 others	50/100
5th	Cognos Therapeutics 2015, Los Angeles (United States), Series B	Provider of an implantable device designed to deliver therapeutic drugs	$6M	-	43/100
6th	Advanced Chemotherapy Technologies 2014, Raleigh (United States), Series A	Developer of a medical device used for chemotherapy	$8M	Khosla Ventures, Spectrumfinancial & 1 others	39/100
7th	Spirea 2016, Harrogate (United Kingdom), Seed	Developer of therapeutic solutions for cancer treatments	$2.93M	meltwind.com, University of Cambridge & 12 others	39/100
8th	AcuityBio 2008, Brookline (United States), Seed	A surgical implant that prevents post-surgical lung cancer recurrence	$2.62M	Bantam Group, HHS	37/100
9th	EmboMedics 2012, Maple Grove (United States), Deadpooled	Bioresorbable embolic beads	$5.9M	Dakota Venture Group, HHS	33/100
10th	DigniCap 2013, Dallas (United States), Public	Scalp cooling system to prevent hair loss associated with chemotherapy in cancer patients	-	-	32/100
12th	Current Surgical 2019, Washington, DC (United States), Seed	Developer of micro-invasive therapies for the treatment of solid tumors	$4M	True Ventures, 1517 Fund & 3 others	31/100